• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病进展的本质:非线性、多变量、纵向随机效应模型的应用。

The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.

机构信息

Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.

出版信息

PLoS One. 2013 Oct 18;8(10):e76595. doi: 10.1371/journal.pone.0076595. eCollection 2013.

DOI:10.1371/journal.pone.0076595
PMID:24204641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3799835/
Abstract

BACKGROUND

To date, statistical methods that take into account fully the non-linear, longitudinal and multivariate aspects of clinical data have not been applied to the study of progression in Parkinson's disease (PD). In this paper, we demonstrate the usefulness of such methodology for studying the temporal and spatial aspects of the progression of PD. Extending this methodology further, we also explore the presymptomatic course of this disease.

METHODS

Longitudinal Positron Emission Tomography (PET) measurements were collected on 78 PD patients, from 4 subregions on each side of the brain, using 3 different radiotracers. Non-linear, multivariate, longitudinal random effects modelling was applied to analyze and interpret these data.

RESULTS

The data showed a non-linear decline in PET measurements, which we modelled successfully by an exponential function depending on two patient-related covariates duration since symptom onset and age at symptom onset. We found that the degree of damage was significantly greater in the posterior putamen than in the anterior putamen throughout the disease. We also found that over the course of the illness, the difference between the less affected and more affected sides of the brain decreased in the anterior putamen. Younger patients had significantly poorer measurements than older patients at the time of symptom onset suggesting more effective compensatory mechanisms delaying the onset of symptoms. Cautious extrapolation showed that disease onset had occurred some 8 to 17 years prior to symptom onset.

CONCLUSIONS

Our model provides important biological insights into the pathogenesis of PD, as well as its preclinical aspects. Our methodology can be applied widely to study many other chronic progressive diseases.

摘要

背景

迄今为止,尚未将充分考虑临床数据的非线性、纵向和多变量方面的统计方法应用于帕金森病(PD)进展的研究。在本文中,我们展示了这种方法在研究 PD 进展的时间和空间方面的有用性。通过进一步扩展这种方法,我们还探索了这种疾病的无症状期过程。

方法

对 78 名 PD 患者的大脑两侧的 4 个分区使用 3 种不同的示踪剂进行了纵向正电子发射断层扫描(PET)测量。应用非线性、多变量、纵向随机效应建模来分析和解释这些数据。

结果

数据显示 PET 测量值呈非线性下降,我们通过依赖于两个与患者相关的协变量(从症状发作到症状发作的持续时间和年龄)的指数函数成功地对其进行了建模。我们发现,在整个疾病过程中,后壳核的损伤程度明显大于前壳核。我们还发现,在疾病过程中,大脑受影响较轻和较重两侧之间的差异在前壳核中逐渐减小。症状发作时,年轻患者的测量值明显比老年患者差,这表明更有效的代偿机制延迟了症状的发作。谨慎的外推表明,疾病发作发生在症状发作前 8 至 17 年。

结论

我们的模型为 PD 的发病机制及其临床前方面提供了重要的生物学见解。我们的方法可以广泛应用于研究许多其他慢性进行性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/2ab2398fa2bb/pone.0076595.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/05d9f63a044a/pone.0076595.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/6b8b4f77dd7e/pone.0076595.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/73d171d715cd/pone.0076595.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/2ab2398fa2bb/pone.0076595.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/05d9f63a044a/pone.0076595.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/6b8b4f77dd7e/pone.0076595.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/73d171d715cd/pone.0076595.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c2c/3799835/2ab2398fa2bb/pone.0076595.g004.jpg

相似文献

1
The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.帕金森病进展的本质:非线性、多变量、纵向随机效应模型的应用。
PLoS One. 2013 Oct 18;8(10):e76595. doi: 10.1371/journal.pone.0076595. eCollection 2013.
2
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.散发性帕金森病的纵向进展:多示踪剂正电子发射断层扫描研究。
Brain. 2009 Nov;132(Pt 11):2970-9. doi: 10.1093/brain/awp209. Epub 2009 Aug 18.
3
Novel data-driven, equation-free method captures spatio-temporal patterns of neurodegeneration in Parkinson's disease: Application of dynamic mode decomposition to PET.一种新颖的、无需建立方程的数据驱动方法捕捉帕金森病神经退行性变的时空模式:动态模式分解在 PET 中的应用。
Neuroimage Clin. 2020;25:102150. doi: 10.1016/j.nicl.2019.102150. Epub 2019 Dec 27.
4
Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.利用[18F]CFT正电子发射断层扫描(PET)研究帕金森病纹状体亚区域多巴胺能功能减退的进展
Synapse. 2003 Jun 1;48(3):109-15. doi: 10.1002/syn.10192.
5
Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.帕金森病起病相关亚型在纹状体多巴胺能功能障碍模式上存在差异:一项正电子发射断层扫描研究。
Parkinsonism Relat Disord. 2015 Dec;21(12):1448-53. doi: 10.1016/j.parkreldis.2015.10.017. Epub 2015 Oct 30.
6
Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.帕金森病患者纹状体亚区 6-[18F]氟多巴摄取率下降。
Mov Disord. 2011 Mar;26(4):614-20. doi: 10.1002/mds.23503. Epub 2011 Mar 29.
7
Age and severity of nigrostriatal damage at onset of Parkinson's disease.帕金森病发病时黑质纹状体损伤的年龄和严重程度。
Synapse. 2003 Feb;47(2):152-8. doi: 10.1002/syn.10160.
8
Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.应用概率追踪技术评估帕金森病纹状体-黑质连接。
Neuroimage Clin. 2017 Sep 9;16:557-563. doi: 10.1016/j.nicl.2017.09.009. eCollection 2017.
9
Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.帕金森病的进展速率:一项6-[18F]氟代-L-多巴正电子发射断层显像研究。
Mov Disord. 2001 Jul;16(4):608-15. doi: 10.1002/mds.1139.
10
An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.早期帕金森病各亚型多巴胺能神经元丢失差异的氟代脱氧苯丙氨酸-碳-11标记的N-甲基-4-苯基-1,2,3,6-四氢吡啶正电子发射断层扫描比较
Acta Radiol. 2014 Apr;55(3):366-71. doi: 10.1177/0284185113498075. Epub 2013 Aug 13.

引用本文的文献

1
Predictive modeling to uncover Parkinson's disease characteristics that delay diagnosis.预测建模以揭示延迟帕金森病诊断的特征。
NPJ Parkinsons Dis. 2025 Apr 2;11(1):64. doi: 10.1038/s41531-025-00923-2.
2
Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.帕金森病黑质纹状体变性进展速率的相关预测因素。
J Neurol. 2024 Aug;271(8):5213-5222. doi: 10.1007/s00415-024-12477-z. Epub 2024 Jun 5.
3
Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis.

本文引用的文献

1
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.帕金森病纹状体多巴胺处理的代偿性变化的纵向演变。
Brain. 2011 Nov;134(Pt 11):3290-8. doi: 10.1093/brain/awr233.
2
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.帕金森病患者黑质纹状体功能的年龄特异性进展。
Ann Neurol. 2011 May;69(5):803-10. doi: 10.1002/ana.22284. Epub 2011 Jan 18.
3
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.散发性帕金森病的纵向进展:多示踪剂正电子发射断层扫描研究。
通过数据驱动的多队列分析确定的帕金森病进展亚型。
NPJ Parkinsons Dis. 2024 May 2;10(1):95. doi: 10.1038/s41531-024-00712-3.
4
Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target.帕金森病中的多巴胺 D3 受体:一个预后生物标志物和干预靶点。
Curr Top Behav Neurosci. 2023;60:89-107. doi: 10.1007/7854_2022_373.
5
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?早期帕金森病的运动和非运动回路障碍:哪个先发生?
Nat Rev Neurosci. 2022 Feb;23(2):115-128. doi: 10.1038/s41583-021-00542-9. Epub 2021 Dec 14.
6
The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.晚期帕金森病中 D1/D5 多巴胺部分激动剂 PF-06412562:一项可行性研究。
J Parkinsons Dis. 2020;10(4):1515-1527. doi: 10.3233/JPD-202188.
7
Parkinson's disease laterality: a C-PE2I PET imaging study.帕金森病的侧别:一项 C-PE2I PET 成像研究。
J Neurol. 2021 Feb;268(2):582-589. doi: 10.1007/s00415-020-10204-y. Epub 2020 Sep 2.
8
Curcumin-Activated Mesenchymal Stem Cells Derived from Human Umbilical Cord and Their Effects on MPTP-Mouse Model of Parkinson's Disease: A New Biological Therapy for Parkinson's Disease.姜黄素激活的人脐带间充质干细胞及其对帕金森病MPTP小鼠模型的影响:帕金森病的一种新的生物疗法
Stem Cells Int. 2020 Feb 17;2020:4636397. doi: 10.1155/2020/4636397. eCollection 2020.
9
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?多巴胺 D3 受体:帕金森病发病机制和治疗中的被忽视的参与者?
Ageing Res Rev. 2020 Jan;57:100994. doi: 10.1016/j.arr.2019.100994. Epub 2019 Nov 22.
10
Clinical progression in Parkinson's disease with features of REM sleep behavior disorder: A population-based longitudinal study.帕金森病伴 REM 睡眠行为障碍特征的临床进展:一项基于人群的纵向研究。
Parkinsonism Relat Disord. 2019 May;62:105-111. doi: 10.1016/j.parkreldis.2019.01.018. Epub 2019 Jan 29.
Brain. 2009 Nov;132(Pt 11):2970-9. doi: 10.1093/brain/awp209. Epub 2009 Aug 18.
4
Functional imaging in Parkinson disease.帕金森病的功能成像
Neurology. 2008 Apr 15;70(16 Pt 2):1478-88. doi: 10.1212/01.wnl.0000310432.92489.90.
5
Changes in network activity with the progression of Parkinson's disease.帕金森病进展过程中网络活动的变化。
Brain. 2007 Jul;130(Pt 7):1834-46. doi: 10.1093/brain/awm086. Epub 2007 Apr 30.
6
How common are the "common" neurologic disorders?“常见”的神经系统疾病有多常见?
Neurology. 2007 Jan 30;68(5):326-37. doi: 10.1212/01.wnl.0000252807.38124.a3.
7
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.早期帕金森病纹状体亚区域6-[18F]氟-L-多巴摄取:一项为期两年的随访研究。
Mov Disord. 2006 Jul;21(7):958-63. doi: 10.1002/mds.20855.
8
Non-linear random effects model for multivariate responses with missing data.用于处理缺失数据的多变量响应的非线性随机效应模型。
Stat Med. 2006 Aug 30;25(16):2817-30. doi: 10.1002/sim.2361.
9
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.携带LRRK2基因突变的帕金森病患者的正电子发射断层扫描:与散发性帕金森病的比较及症状前代偿的证据
Brain. 2005 Dec;128(Pt 12):2777-85. doi: 10.1093/brain/awh607. Epub 2005 Aug 4.
10
Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.
Brain Res Mol Brain Res. 2005 Mar 24;134(1):24-33. doi: 10.1016/j.molbrainres.2004.09.028. Epub 2004 Nov 2.